Encompass Health Corporation (EHC) has been highlighted as a stock to watch with a Zacks Rank #2 (Buy) rating and a VGM Score of A. The company, a provider of integrated healthcare services with 173 hospitals across 39 states and Puerto Rico, benefits from growing demand for coordinated care models. Recent analyst revisions have increased fiscal 2026 earnings estimates to $6.08 per share, with the stock showing an average earnings surprise of +6.8%.

Encompass Health Corporation (EHC) opened its first wholly owned hospital in Maine with 50 inpatient rehabilitation beds. Q2 2026 discharges rose 5.6% year-over-year, driven by new capacity and 2.8% same-store growth. EHC opened three hospitals in the first half of 2026 and plans to open eight new hospitals throughout the year, reflecting its strategy to expand capacity in favorable markets.

Encompass Health (EHC) is presented as a potential growth investment pick with a #3 (Hold) Zacks Rank and an A VGM Score. The company, which operates 173 inpatient rehabilitation hospitals across 39 states and Puerto Rico, shows strong growth prospects with forecasted year-over-year earnings growth of 11.6% for fiscal 2026. Seven analysts have raised earnings estimates in the last 60 days, with the consensus estimate increasing to $6.08 per share and an average earnings surprise of +6.8%.

Encompass Health's EVP and general counsel John Patrick Darby sold 8,906 shares (11% of his direct holdings) for $1.1 million on August 10, 2026, following strong earnings and a stock rally. The sale comes after the company raised guidance due to a favorable 2.3% Medicare rate increase for inpatient rehabilitation services starting in October. While multiple insiders trimmed positions after the earnings-driven rally, the article emphasizes that Medicare reimbursement rates are the key factor for investors to monitor, as they directly impact the company's pricing and profitability.

Encompass Health's CFO Douglas Coltharp sold 18,869 shares worth $2.4 million on August 10, reducing his direct stake by 27% but maintaining a total beneficial ownership of 241,000 shares valued at $30.4 million. The sale occurred the same day as the CEO's larger stake reduction, following strong Q2 earnings that included 10% revenue growth, raised full-year guidance, and increased dividend/buyback authorization.

The healthcare sector added 35,200 jobs in May, with ambulatory services leading at 25,700 positions and hospitals adding 6,000. This consistent job growth signals sustained demand for healthcare services and revenue opportunities for companies positioned in ambulatory care, managed care, and inpatient rehabilitation. Three stocks are highlighted as beneficiaries of this trend: UnitedHealth Group, HCA Healthcare, and Encompass Health.

Encompass Health Corp. (NYSE: EHC) announced that its board of directors has declared a quarterly cash dividend of $0.19 per share, payable on July 15, 2026, to shareholders of record on July 1, 2026. The company is the largest owner and operator of inpatient rehabilitation hospitals in the United States with 175 hospitals across 39 states and Puerto Rico.

Pomerantz LLP is investigating potential securities fraud claims against Encompass Health Corporation following a New York Times article alleging that Encompass-owned for-profit hospitals perform below average on safety measures, with 34 facilities rated as having statistically significantly worse rates of preventable readmissions. The stock fell 10.35% following the publication.

Pomerantz LLP announced investigations into potential securities fraud at Confluent, GoDaddy, and Encompass Health. The investigation into Confluent was triggered by the company's disclosure that a major AI-native customer is reducing spending, which caused the stock to plunge 32.86% on July 31, 2025. Investors are being solicited to join class action lawsuits against these companies.

The Portnoy Law Firm has initiated an investigation into possible securities fraud at Encompass Health Corporation following a July 15, 2025 New York Times report alleging that the company's for-profit hospitals perform below average on key safety measures. The report highlighted alarming mistakes leading to patient fatalities and noted that 34 Encompass facilities had statistically significantly worse rates of potentially preventable readmissions. Encompass's stock fell 10.4% to $107.28 per share following the disclosure.

Encompass Health Corp. (NYSE: EHC) announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.19 per share, payable on April 15, 2026, to shareholders of record on April 1, 2026.

Rosen Law Firm is investigating potential securities claims for Encompass Health shareholders following a New York Times article alleging serious patient safety incidents in their rehabilitation hospitals.